The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Is The Market Size Of The Oxycodone Hydrochloride Market Expected To Change Between 2026 And 2030?
The oxycodone hydrochloride market size has shown consistent expansion over recent years. It is projected to increase from $4.32 billion in 2025 to $4.49 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 4.0%. This growth observed in the past can be ascribed to the increasing prevalence of chronic pain conditions, the extensive use of opioids in post-surgical care, the restricted availability of alternative pain therapies, robust hospital-based prescribing methods, and the well-established oral opioid formulations.
The oxycodone hydrochloride market size is anticipated to experience consistent expansion over the upcoming years, with projections indicating it will reach $5.18 billion by 2030, growing at a compound annual growth rate (CAGR) of 3.6%. This growth during the forecast period is primarily attributed to advancements in abuse-deterrent and tamper-resistant formulations, a heightened focus on controlled and regulated opioid use, the expansion of generic drug manufacturing, the increasing incidence of cancer and the resulting demand for palliative care, and innovations in pain management delivery systems. Major trends expected in this period include an escalating demand for effective pain management therapies, the increasing adoption of extended-release and abuse-deterrent formulations, a rise in prescriptions for post-surgical and cancer-related pain, a shift towards generic and more cost-effective opioid formulations, and enhanced regulatory oversight alongside controlled distribution.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24646&type=smp
What Underlying Factors Are Accelerating The Growth Of The Oxycodone Hydrochloride Market?
The expanding occurrence of chronic pain is anticipated to stimulate the expansion of the oxycodone hydrochloride market. Defined as discomfort lasting three months or more, chronic pain significantly impacts patients’ daily lives and necessitates more effective pain-management solutions. The growing number of chronic pain cases stems primarily from factors such as obesity, an aging populace, and musculoskeletal conditions, which contribute to the rise of ailments like osteoarthritis and lower back pain. Oxycodone hydrochloride assists in managing chronic pain by targeting neurological pain receptors, thereby offering relief from moderate-to-severe pain and enhancing patient well-being and functional capacity. For instance, in November 2024, data from the U.S. National Center for Health Statistics (NCHS) indicated that 24.3% of U.S. adults experienced chronic pain, with 8.5% reporting high-impact chronic pain, which restricts life or work activities. Consequently, the rising incidence of chronic pain is a key factor propelling the oxycodone hydrochloride market.
How Is The Oxycodone Hydrochloride Market Structured Across Different Segments?
The oxycodone hydrochloride market covered in this report is segmented –
1) By Product: Extended Release Tablets, Immediate Release Tablets, Oral Solutions
2) By Route Of Administration: Oral, Parental
3) By Application: Pain Management, Post Surgical Pain, Cancer Related Pain
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End User: Hospitals, Clinics, Homecare
Subsegments:
1) By Extended Release Tablets: Abuse-Deterrent Formulations, Non-Abuse-Deterrent Formulations
2) By Immediate Release Tablets: Combination Products, Single-Agent Formulations
3) By Oral Solutions: Concentrated Solutions, Standard Solutions
Which Trends Are Shaping The Future Of The Oxycodone Hydrochloride Market?
Major companies in the oxycodone hydrochloride market are concentrating on developing advanced products, such as combination therapies, to improve pain management effectiveness while mitigating the risks of opioid dependency. Combination therapies are treatment strategies that employ two or more medications or therapeutic agents together to enhance efficacy, target multiple pathways, or reduce the potential for resistance. For example, in April 2025, Elite Pharmaceuticals Inc., a US-based pharmaceutical company, introduced a generic version of Percocet (oxycodone hydrochloride and acetaminophen tablets, USP CII). This combination product is offered in three strengths: mg/325 mg, 10 mg/325 mg, and 325 mg tablets. It is prescribed for moderate to moderately severe pain relief, blending the opioid oxycodone for powerful pain reduction with acetaminophen to boost its analgesic effects. As a Schedule II controlled substance, it carries a high likelihood of abuse and dependence, demanding careful medical oversight.
Which Major Players Dominate The Oxycodone Hydrochloride Market?
Major companies operating in the oxycodone hydrochloride market are Viatris Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Endo Pharmaceuticals Inc., Lupin Ltd., Mallinckrodt Pharmaceuticals Inc., ANI Pharmaceuticals Inc., Purdue Pharma L.P., Alvogen Inc., Camber Pharmaceuticals, Noramco Inc., Rhodes Pharmaceuticals L.P., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Aurobindo Pharma Ltd., Zydus Lifesciences Ltd., Dr. Reddy’s Laboratories Ltd., Apotex Inc., Mylan N.V., Cipla Ltd., Torrent Pharmaceuticals Ltd., Sandoz International GmbH, Pfizer Inc., Novartis AG, Accord Healthcare Ltd., Glenmark Pharmaceuticals Ltd., Fresenius Kabi AG
Read the full oxycodone hydrochloride market report here:
https://www.thebusinessresearchcompany.com/report/oxycodone-hydrochloride-global-market-report
Which Region Is Projected To Dominate The Oxycodone Hydrochloride Market During The Forecast Period?
North America was the largest region in the oxycodone hydrochloride market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oxycodone hydrochloride market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Oxycodone Hydrochloride Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24646&type=smp
Browse Through More Reports Similar to the Global Oxycodone Hydrochloride Market 2026, By The Business Research Company
Oxycodone Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/oxycodone-drugs-global-market-report
Hydrochloric Acid Market Report 2026
https://www.thebusinessresearchcompany.com/report/hydrochloric-acid-global-market-report
Oxalic Acid Market Report 2026
https://www.thebusinessresearchcompany.com/report/oxalic-acid-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model